Role of the proto-oncogene Pokemon in cellular transformation and ARF repression (original) (raw)

• Lin, R. J. et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391, 811–814 (1998)
  Article ADS CAS Google Scholar
• Melnick, A. et al. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol. Cell. Biol. 22, 1804–1818 (2002)
  Article CAS Google Scholar
• Barna, M., Hawe, N., Niswander, L. & Pandolfi, P. P. Plzf regulates limb and axial skeletal patterning. Nature Genet. 25, 166–172 (2000)
  Article CAS Google Scholar
• Ye, B. H. et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Genet. 16, 161–170 (1997)
  Article CAS Google Scholar
• Adhikary, S. et al. Miz1 is required for early embryonic development during gastrulation. Mol. Cell. Biol. 23, 7648–7657 (2003)
  Article CAS Google Scholar
• Carter, M. G. et al. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller–Dieker syndrome. Hum. Mol. Genet. 9, 413–419 (2000)
  Article CAS Google Scholar
• Chen, W. Y. et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genet. 33, 197–202 (2003)
  Article ADS CAS Google Scholar
• Chen, Z. et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J. 12, 1161–1167 (1993)
  Article CAS Google Scholar
• Ye, B. H. et al. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262, 747–750 (1993)
  Article ADS CAS Google Scholar
• Davies, J. M. et al. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18, 365–375 (1999)
  Article CAS Google Scholar
• Kukita, A. et al. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94, 1987–1997 (1999)
  CAS PubMed Google Scholar
• Pessler, F., Pendergrast, P. S. & Hernandez, N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol. Cell. Biol. 17, 3786–3798 (1997)
  Article CAS Google Scholar
• Weinberg, R. A. The cat and mouse games that genes, viruses, and cells play. Cell 88, 573–575 (1997)
  Article CAS Google Scholar
• Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424–2433 (1998)
  Article CAS Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997)
  Article CAS Google Scholar
• Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119–128 (1992)
  Article CAS Google Scholar
• de Stanchina, E. et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev. 12,2434–2442 (1998)
  Article CAS Google Scholar
• Wright, W. E., Binder, M. & Funk, W. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11, 4104–4110 (1991)
  Article CAS Google Scholar
• Bates, S. et al. p14ARF links the tumour suppressors RB and p53. Nature 395, 124–125 (1998)
  Article ADS CAS Google Scholar
• Rowland, B. D. et al. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest. Cancer Cell 2, 55–65 (2002)
  Article CAS Google Scholar
• Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene _bmi_-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164–168 (1999)
  Article ADS CAS Google Scholar
• Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678–2690 (1999)
  Article CAS Google Scholar
• Smith, K. S. et al. Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol. Cell 12, 393–400 (2003)
  Article CAS Google Scholar
• Kranc, K. R. et al. Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Mol. Cell. Biol. 23, 7658–7666 (2003)
  Article CAS Google Scholar
• Kim, J. H. et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 203, 217–224 (2004)
  Article CAS Google Scholar
• Vonlanthen, S. et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84, 1372–1376 (2001)
  Article CAS Google Scholar
• Jacobs, J. J. et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nature Genet. 26, 291–299 (2000)
  Article CAS Google Scholar
• Lingbeek, M. E., Jacobs, J. J. & van Lohuizen, M. The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator. J. Biol. Chem. 277, 26120–26127 (2002)
  Article CAS Google Scholar
• Brummelkamp, T. R. et al. TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence. J. Biol. Chem. 277, 6567–6572 (2002)
  Article CAS Google Scholar
• Inoue, K., Roussel, M. F. & Sherr, C. J. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc. Natl Acad. Sci. USA 96, 3993–3998 (1999)
  Article ADS CAS Google Scholar
• Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993–1000 (1995)
  Article CAS Google Scholar
• Sherr, C. J. & McCormick, F. The RB and p53 pathways in cancer. Cancer Cell 2, 103–112 (2002)
  Article CAS Google Scholar
• Lowe, S. W. & Sherr, C. J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13, 77–83 (2003)
  Article CAS Google Scholar
• Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo . Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995)
  Article ADS CAS Google Scholar
• Iritani, B. M., Forbush, K. A., Farrar, M. A. & Perlmutter, R. M. Control of B cell development by Ras-mediated activation of Raf. EMBO J. 16, 7019–7031 (1997)
  Article CAS Google Scholar
• Morse, H. C. III et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246–258 (2002)
  Article CAS Google Scholar
• Donlon, J. A., Jaffe, E. S. & Braylan, R. C. Terminal deoxynucleotidyl transferase activity in malignant lymphomas. N. Engl. J. Med. 297, 461–464 (1977)
  Article CAS Google Scholar
• Jaffe, E. S., Harris, N. L., Stein, H. & Vardiman, J. W. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, France, 2001)
  Google Scholar
• Whitehurst, C. E., Chattopadhyay, S. & Chen, J. Control of V(D)J recombinational accessibility of the D beta 1 gene segment at the TCR beta locus by a germline promoter. Immunity 10, 313–322 (1999)
  Article CAS Google Scholar
• Gurrieri, C. et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst. 96, 269–279 (2004)
  Article CAS Google Scholar
• Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000)
  Article ADS CAS Google Scholar
• Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937–1947 (2002)
  Article Google Scholar
• Hans, C. P. et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103, 275–282 (2004)
  Article CAS Google Scholar
• Shvarts, A. et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling. Genes Dev. 16, 681–686 (2002)
  Article CAS Google Scholar
• Lossos, I. S. et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350, 1828–1837 (2004)
  Article CAS Google Scholar
• Sanchez-Beato, M., Sanchez-Aguilera, A. & Piris, M. A. Cell cycle deregulation in B-cell lymphomas. Blood 101, 1220–1235 (2003)
  Article CAS Google Scholar
• Phan, R. T. & Dalla-Favera, R. The BCL6 proto-oncogene suppresses p53 expression in germinal-center B cells. Nature 432, 635–639 (2004)
  Article ADS CAS Google Scholar
• Carnero, A., Hudson, J. D., Price, C. M. & Beach, D. H. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nature Cell Biol. 2, 148–155 (2000)
  Article CAS Google Scholar
• Hedvat, C. V. et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum. Pathol. 33, 968–974 (2002)
  Article Google Scholar